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One of the current barriers proposed to avoid possible medication errors, and consequently harm to 
patients, is the medication reconciliation, a process in which drugs used by patients prior to hospitalization 
can be compared with those prescribed in the hospital. This study describes the results of a pharmacist 
based reconciliation conducted during six months in clinical units of a university hospital. Fourteen 
patients (23.33%) had some kind of problem related to medicine. The majority (80%) of medication 
errors were due to medication omission. Pharmaceutical interventions acceptance level was 90%. The 
results suggest that pharmacists based reconciliation can have a relevant role in preventing medication 
errors and adverse events. Moreover, the detailed interview, conducted by the pharmacist, is able to rescue 
important information regarding the use of drugs, allowing to avoid medications errors and patient injury.
Uniterms: Medication reconciliation. Medications/errors/ion Medications/adverse events/prevention. 
Patient safety. Pharmacist/professional performance.
Uma das barreiras propostas para se evitar possíveis erros relacionados a medicamentos e, 
consequentemente, que danos acometam o paciente, é a reconciliação medicamentosa no ato da internação, 
processo no qual se comparam os medicamentos usados pelos pacientes previamente à internação com 
os prescritos no âmbito hospitalar. Este trabalho descreve os resultados de seis meses de um processo de 
reconciliação conduzido por farmacêutico em unidades clínicas de um hospital universitário. Quatorze 
pacientes (23.33%) tiveram algum tipo de problema relacionado ao uso de medicamentos. A maioria dos 
erros envolvendo medicamentos (80%) estava relacionada à omissão de medicamentos. As intervenções 
farmacêuticas tiveram 90% de aceitação pelos médicos. Os resultados sugerem que a atuação de 
farmacêuticos na reconciliação medicamentosa pode desempenhar papel relevante na prevenção de erros 
de medicamentos e eventos adversos. Além disso, a entrevista detalhada conduzida por um farmacêutico 
se mostrou capaz de resgatar informações importantes sobre o uso dos medicamentos, permitindo evitar 
erros e danos ao paciente. 
Unitermos: Reconciliação medicamentosa. Medicação/erros/prevenção. Medicação/eventos adversos/
prevenção. Paciente/segurança. Farmacêutico/atuação profissional.
INTRODUCTION
Health care innovations, including new medicines, 
have been providing improvements in the quality and life 
expectancy of thousands of people, but also make the 
health care process increasingly expensive and complex 
(Rosa, Perini, 2003; Chambers et al., 2014). In addition, 
drug use safety concept is also changing as there involves 
the knowledge in pharmacology, health care safety and 
many other areas of knowledge (Rosa, Perini, 2003; 
Gottlieb, 2007), demanding actions to assure the best 
benefits with lower risk of harm to patients (Moran, 
Scanlon, 2013). 
In this scenario, the safe use of medicines became 
one of the most significant challenges to be faced by all 
the health care stakeholders, including scientific societies, 
health organizations and hospitals around the world 
(Moran, Scanlon, 2013).
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Since 1990s, many publications contributed to the 
knowledge and awareness of the importance of medication 
errors (Hartwig et al., 1991; Leape et al., 1991; Kohn et 
al., 2001; Otero et al., 2002; Rosa, Perini, 2003; WHO, 
2007; Smith et al., 2014; Call et al., 2014). From then on, 
researchers in the health field focused their attention to 
this problem, previously unnoticed in everyday of health 
professionals that deal with medicine use.
A medication error can be defined as any error that 
occurs within the medication use process (Otero et al., 
2002). The National Coordinating Council for Medication 
Error Reporting and Prevention (NCCMERP, 2014) 
describes it as “any incident, which can be prevented, 
which can cause harm to the patient or lead to inappropriate 
use of drugs, when they are beyond the control of the 
health professionals, the patient or the consumer”.
It is estimated that the damage caused by medication 
errors affects 1.5 million people each year in the U.S., and 
thousands of them die (WHO, 2007). In some countries 
more than 67% of prescriptions have one or more errors 
at different times during patient care, with prevalence in 
hospitalized patients (WHO, 2007).
A retrospective study including all hospital 
admissions of adults in medical and surgical clinics in 
Brazil, in 2007, showed 3.6 potential adverse events per 
1,000 admissions, with a greater frequency in medical 
clinics (5.3 per 1,000). Besides the harm to the patient, 
these events were also associated with increased health 
expenditures, days of hospital stay and mortality (Dias 
et al., 2012).
In Brazil, a multicenter study in clinical units of 
five hospitals showed 1,500 errors among 4,958 drug 
administration observations (30.24%). Among those 
errors, 277 (18.5%) were related to antimicrobial agents 
(Marques et al., 2008).
Despite the growing number in recent years, there 
are still few studies both on drug related adverse events 
and on understanding and evaluating the magnitude and 
the impact generated by adverse events in health care 
institutions in Brazil (Gallotti, 2003; Mendes et al., 2008; 
Marques et al., 2008; Rozenfeld et al., 2009, Giordani, 
Rozenfeld, 2009; Reis, Cassiani, 2011; Giordani et al., 
2012; Roque et al., 2012; Ventura et al., 2012; Dias et al., 
2012; Rozenfeld, Giordani, 2013; Mendes et al., 2013).
Medication errors’ reduction should permeate 
planned and systematic preventive measures. A systematic 
approach is based on the central idea that it is necessary 
to change health professionals’ working conditions 
through deployment of defense mechanisms, barriers 
and protections in the organizational system. When a 
system fails, multiple errors occurred simultaneously, 
interrelated, unexpectedly, what creates a chain of events 
in which errors grow and evolve, resulting in an accident. 
The errors that occur in this chain are potentially harmful 
to the patient. Therefore, should be prevented, avoided, 
and corrected.
Medication reconciliation is one of the barriers 
proposed to reduce medication errors in health care 
transitions (Chhabra et al.,2011; Knez et al., 2011; 
Hellstrom et al., 2012). It is a formal process of continuous 
care that consists of three steps for gathering data: check 
(patient medication history), clarification (confirmation 
if the doses, dosages and instructions on medicines are 
used correctly by the user) and the reconciliation itself 
(documentation of changes and requirements) (Chhabra 
et al., 2011). 
The importance of medication reconciliation resides 
in the fact that preventable adverse drug events (ADE) 
at transition points of care account for 46-56% of all 
medication errors (Chhabra et al., 2011). Omission of 
medications previously used by patients accounts for 42% 
to 60% of those errors, both at admission and at discharge, 
followed by differences in dose, frequency, time, route 
and form of administration. The reconciliation process 
is associated with 43% prevention of adverse events and 
medication errors on admission (Boockvar et al., 2011).
A drug discrepancy can involve omission of any 
medication (any item not prescribed), extra medication, 
unnecessarily prescribed, high or low doses or wrong 
medication dosage form (Hellstrom et al., 2012). About 
22% of drug discrepancies can cause harm to the patient 
during hospitalization, and 59% of them may remain 
after discharge (Boockvar et al., 2011). Studies have 
reported the frequency and consequences of discrepancies 
in treatments, and some authors pointed out that more 
than 50% of the patients had at least one discrepancy not 
justified at admission (Cornish et al., 2005). 
It has been shown that pharmacists can contribute 
in improving the quality and safety of medication use 
during in patients’ care, through medication reconciliation 
strategies (Vira et al., 2006; Lubowski et al., 2007; 
Cobaugh et al.,2008; Pippins et al., 2008; Coffey et al., 
2009; Stone et al., 2010; Miranda et al., 2012; Chhabra 
et al., 2012).
The objective of this study was to evaluate a 
pharmacist driven medication reconciliation at hospital 
admission as a tool in the prevention of medication errors.
MATERIAL AND METHODS 
The study was conducted at a University hospital 
in the city of Niterói. This hospital is the reference in the 
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Metropolitan Region II in Rio de Janeiro state. It covers 
more than 2 million people who reside in the cities of 
Niterói, São Gonçalo, Itaboraí, Rio Bonito, Marica, Silva 
Jardim and Tanguá.
For six months, from January to June 2012, a 
prospective study involving the Medication Reconciliation 
with inpatient, in female and male Medical Clinic 
units, was performed. Those clinics meet the following 
specialties: dermatology, endocrinology, nephrology, 
pulmonology, medical clinic, gastroenterology, neurology 
and cardiology.
All the patients admitted both through emergency 
care or elective procedures among the various specialties, 
18 years or older, were invited to participate at the study. 
Only non-responsive and psychiatric patients were 
excluded from the study. Each patient was contacted 
and interviewed by the pharmacist within 48 hours after 
admission. The data relating to patients and medications 
used were recorded in the appropriate form.
The list of medications taken by the patient prior 
to hospital admission, collected by the pharmacist, was 
compared to the patient prescription upon admission. 
Medical records and prescriptions were also analyzed 
during the medication reconciliation.
When observed some discrepancy as omission 
of any medicine, diverging dose from usual or drug 
interaction, the clinical team was contacted and the case 
discussed with those responsible for the patient. For each 
contact the acceptance of the pharmaceutical intervention 
proposal was registered. The potential for harm to the 
patient of the observed error was also discussed with the 
health care team. No intervention or amendment were 
performed without the clinical team consent, which was 
completely free to deny the suggestion made. 
The Medication Errors found were classified 
according to the National Coordinating Council for 
Medication Error Reporting and Prevention (NCCMERP, 
2012). The doses above the daily maximum permitted or 
under dosing were determined by the hospital clinical 
protocols and recognized references in the field (ASHP, 
2012; Thomson, 2012). Differences between the dose 
prescribed and the dose reported by the patient were also 
considered. It was considered that any discrepancies were 
unintentional, and all of them were discussed with the 
health care team.
Data were tabulated in a Microsoft Excel® 
spreadsheet. For establish the drug use profile and 
types of medication errors, as well as pharmaceutical 
interventions and grade of acceptance, descriptive statistic 
was applied. To identify variables that could be considered 
risk factors for the occurrence of problems, statistical 
tests were performed with a confidence interval of 95% 
and a significance level of p-value ≤ 0,05. The numeric 
variables (number of medications taken and patients’ age) 
were analyzed through t-Student test. For the analysis 
of dichotomous variables (day or night admission, 
emergency or elective admission) the chi-square test was 
applied. Those analyzes were performed using S-Plus 8.0 
software.
For medications classification the ATC (Anatomical 
Therapeutic Chemical Classification) classification, as 
recommended by the World Health Organization (WHO), 
was used.
The research was conducted within the ethical 
standards and approved by the ethics committee according 
to the Resolution 196/96 from CNS (CEP-CMM/HUAP 
277/2011), active at the moment of the study development. 
This study presents no real or potential conflict of interest 
from the authors. 
RESULTS AND DISCUSSION
During the data collection period, 79 patients were 
admitted to the Masculine and Feminine Medical Clinics. 
Twelve of them did not have any prior information (neither 
medical records nor reports from the patient and/or care 
giver) regarding the medication use, two patients refused 
to participate on this study and five were considered 
disoriented and unable to answer questions. So, 60 patients 
were included in the study: 32 females and 28 males, with 
an age average of 50.87 years (SD = 14.37). 
The most frequent comorbidities were hypertension 
(41.9%), diabetes mellitus (17.4%), lupus (3.5%), chronic 
renal failure (4, 6%) and depression (2.3%). Eleven patients 
(18.3%) had some type of drug allergy. The drugs related 
to allergies were dipyrone (20%), penicillin (26.6%), 
gentamicin (6.6%), iodine (20%), sulfa (6.6%), omeprazole 
(6.6%), ranitidine (6.6%) and vancomycin (6.6%).
A total of 260 medicines were used previously 
to admission (Figure 1). Of those, 75.4% were kept 
in prescriptions during hospitalization, 18.45 % were 
suspended, according to clinical judgment and decision 
of the physician responsible for the patient, and 6.15% 
represented omission errors.
The average of medications taken by patients 
before admission was 4.3 (SD = 2.94). It is important to 
consider that this information may has a certain grade of 
imprecision since many patients did not know or remember 
exactly all the details about their previous medications. 
The major anatomical groups (ATC classification) were 
cardiovascular system (25%), nervous system (22.5%), 
alimentary tract and metabolism (20%) (Table I).
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After admission, the average of medications per 
patient was 6.3 with emphasis on the following anatomic 
groups: cardiovascular system (21.4%), alimentary 
tract and metabolism (20.4%), nervous system (16.3% ) 
(Table I).
For 14 patients (23,3%), at least one pharmaceutical 
intervention was necessary. This result is similar to that 
observed by Tjia and collaborators (2009), who found 
21.3% medication discrepancies, but in a population of 
199 patients. However, it is lower than the value observed 
in other studies. Gleason et al. (2011) found that 35.9% 
of the patients had at least one discrepancy at transitions 
and clinical handoffs. Vira et al. (2006) found that 60% 
of the patient had at least one unintended variance and 
that 18% had at least one clinically important unintended 
variance. Franco-Donat et al. (2010) found that 42% of 
102 patients submitted to a reconciliation process showed 
a drug related problem. Knez et al. (2011) found that 
74.3% of in-patient therapy were in discordance with the 
patients’ pre-admission therapy but most were intentional 
discrepancies and only 8.3% of them corresponded 
to drug errors. Hellstrom et al. (2012) found that at 
least one medication history error was identified by 
pharmacists conducting medication reconciliations in 
47% of the patients. Becerra-Camargo et al. (2013) found 
that 93,6% of the patients had at least one admission 
discrepancy. 
A total of 26 interventions (Table II) were made. 
None of the 26 errors observed were considered intentional. 
All the dose problems were related to the reconciliation 
process and not with doses out of the limits proposed at 
the literature. Table III illustrates some of the problems 
identified as well as the proposed intervention. It was 
observed a 90% level of acceptance of the interventions 
proposed by the pharmacy, which is in accordance with 
the results of Vira et al. (2006) and Hellstrom et al. (2012) 
that obtained 98% and 94% of physicians’ acceptance, 
respectively. A lower acceptance level (48%) was observed 
by Lubowski et al. (2007). The authors attribute that to the 
lack of time to solve drug-related problems. 
Anti-hypertensives was the class of medication 
more frequently involved in medication errors (20%), 
followed by antimalarial (10%) and anti-anemic, 
antiemetic, antipsychotic, anti-allergic, anti-anxiety, anti-
coagulant, anti-vertigo, bone resorption inhibitor, vitamin, 
immunosuppressant, antilipemic and cardio tonics 
(representing 5% of total each). Carvedilol (C07AG02) 
and hydroxychloroquine (P01BA02) were the drugs more 
TABLE I - Percentage of use of each therapeutic group before and after hospitalization, Niteroi, 2012, N=260
Before hospitalization After hospitalization
ATC Group Use (%) ATC Group Use (%)
Cardiovascular System (C) 25,00 Cardiovascular System (C) 21,42
Nervous System (N) 22,50 Alimentary Tract and Metabolism(A) 20,40
Alimentary Tract and Metabolism (A) 20,00 Nervous System (N) 16,32
Blood and Blood Forming Organs (B) 8,75 Antiinfectives for Systemic Use (J) 12,24
Antineoplastic and Immunomodulating Agents (L) 5,00 Blood and Blood Forming Organs (B) 10,20
Systemic Hormonal Preparations, excl. Sex 
hormones and Insulins (H)
3,75 Systemic Hormonal Preparations, excl. Sex 
hormones and Insulins (H)
4,08
Musculo-Skeletal system (M) 3,75 Antineoplastic and Immunomodulating Agents (L) 4,08
Respiratory System (R) 3,75 Musculo-Skeletal System (M) 4,08
Antiinfectives for Systemic Use (J) 2,50 Respiratory System (R) 4,08
Antiparasitic Products, Insecticides and Repellents 
(P)
2,50 Antiparasitic Products, Insecticides and Repellents 
(P)
2,04
Genito Urinary System and Sex Hormones (G) 1,25 Various (V) 1,02
Various (V) 1,25
TABLE II - Pharmaceutical Interventions, Niteroi, 2012, N=26
Intervention type Number of occurrence
Medication inclusion recommended 16
Dose adjustment (higher dose) 1
Dose adjustment (lower dose) 2
Medication discontinuation 7
Total 26
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often involved in pharmaceutical interventions (8.7% 
each).
Omission was the main (61.54%) category of 
errors identified, followed by dosing errors (11.54%) 
and incorrect medication (3.85%). According to the 
NCCMERP classification, the majority of the errors 
(80%) was classified as B category (the error occurs, but 
does not reach the patient), followed by class C (15%) 
(the error reach the patient, but does not cause harm). 
Omission errors were also the most frequent problem 
identified by many authors (Lubowski et al., 2007; 
Pippins et al., 2008; Salanitro et al., 2012; Hellstrom 
et al., 2012). Dosing errors level is also in accordance 
with the literature (Pippins et al., 2008; Stone et al., 
2010). The percentage of switched medications (4%) 
was similar to that found by Hellstrom et al. (2012), who 
observed 5% of this problem. 
Among the medication omissions, some situations 
call attention. A patient taking levothyroxine and other 
patient taking haloperidol, regularly before admission, have 
neither those medications, nor any other related prescribed 
after hospitalization. The suggestion of inclusion of the 
medications was promptly accepted by the physician. 
Another case of great relevance was a patient 
who had systemic lupus erythematosus, three years on 
treatment, and osteoporosis but had neither record of 
the diseases, nor prescription drugs to treat them in their 
files. During the reconciliation an old prescription was 
discovered. Just then the physician was aware of the health 
problems and could prescribe the medication. Three cases 
of omission of antihypertensive drugs were found and 
immediately incorporated.
Another case that drew attention was a patient on 
erythropoietin 4000 IU, three times a week, regularly 
prescribed. Observing the records of the day before, it was 
found that the drug was not administered because it was not 
available at the hospital. Contacting the pharmacy service, 
it was observed that there was erythropoietin 10,000 IU in 
stock, but to be released, it would be necessary a change 
in the prescription. The physician was contact, made the 
change and the patient could finally receive the medication 
he needed.
In our study, 75% of the problems identified could 
have led to damage to the patients if not identified. This 
result is in accordance with Vira et al. (2006), who 
considered that of the 20 (18%) of clinically important 
variances found, 75% could have lead to patients’ harm 
if not intercepted. However, other studies found a lower 
proportion of harm related to drug errors. Becerra-
Camargo et al. (2013) considered that only 42.7% of the 
errors could lead to a patient discomfort and Salanitro et 
al. (2012) pointed out that only 59% of the errors could 
result in harm for the patient. 
There was no statistical significance between the 
number of medicines taken for each patient and the 
occurrence of drug related problems (p = 0.072). This 
result differs from the analysis of Lubowski et al. (2007), 
Gleason et al. (2011) and Hellstrom et al. (2012), but is 
in accordance with the results of Cornish et al. (2005). 
Patients’ age has no statistical relationship with drug 
TABLE III - Examples of Drug Related Problems Identified and interventions. Niterói, 2012
Identified Problem Intervention
Patient was taking simvastatin 20 mg before admission. There was neither 
simvastatin or another drug in the same class or replacement.
Physician was informed of the omission 
and medicines included..
Patient, who had systemic lupus erythematosus, three years on treatment, and 
osteoporosis. The medications to treat these pathologies were not prescribed at 
admission. 
Physician was informed of the omission 
and medicines included.
Patients using hydroxychloroquine, azathioprine, flunarizine, haloperidol, 
promethazine, digoxin, levothyroxine, and carvedilol prior to admission without 
prescription at hospital admission.
Physician was informed of the omission 
and medicines included.
Patient using captopril 25 mg of 8 in 8 hours prior hospitalization. The dose was 
doubled the admission prescription, with no history of hypertensive crisis or any 
other medical condition that would justify dose modification.
Physician was informed and the dose 
adjusted.
Patient reported insomnia on the first night in the hospital, by making use of 
tranquilizer at night, which was not communicated to the physician in the hospital.
Physician was informed of the omission 
and medicines included.
Patient was diagnosed with deep vein thrombosis and with anticoagulant indication 
in the chart, however, the drug was not prescribed.
Physician was informed of the omission 
and medicines included.
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related problem (p = 0,837), which is in accordance with 
the results of Hellstrom et al. (2012). However, Gleason 
et al. (2011) found a significant relationship between drug 
related problems and age > 65 years. 
A total of 53% of the interventions occurred with 
female patients. The gender showed a statistical significant 
relationship with drug related problems (p = 0.013), 
differing from the results of Hellstrom et al. (2012), in 
which this parameter was not significant.
The Chi-square test showed that the period of 
hospitalization (day or night) and type of admission 
(elective or emergency), had no significant relation with 
the occurrence of drug related problems (p-values 0.133 
and 0.532, respectively), which is in accordance with the 
results of Gleason et al. (2011).
Despite the limited number of patients and short 
time of observation, important limitations of this study, 
it is possible to consider that the pharmacist participation 
in the medication reconciliation process has a potential to 
collaborate with a safer use of medicines. Other authors 
have pointed out this aspect (Vira et al., 2006; Lubowski 
et al., 2007; Cobaugh et al.,2008; Pippins et al., 2008; 
Coffey et al., 2009; Stone et al., 2010; Miranda et al., 
2012; Chhabra et al., 2012; Haynes et al., 2012).
The possibility of identifying a drug related problem 
during admission reconciliation is directly related to 
patients’ drug history. Some authors call attention to the 
difficulty of obtaining this information, the presence of 
incomplete data, to the inadequate communication and to 
the patients lack of understanding regarding their treatment. 
The importance of reliable drug history available before 
initiating reconciliation is also emphasized (Coffey et al., 
2009; Salanitro et al., 2012). This aspect was particularly 
important in this study since it was observed constant 
lack of information in the medical records, which often 
diminished the reconciliation contribution to avoid drug 
related problems. In this study, it was observed a high level 
of patients’ misinformation about the medicines they use. 
Twelve patients were admitted in the study period but the 
reconciliation was not possible because they were not able 
to inform any data on what they used before getting to the 
hospital. Also, there were no prescriptions with them. So, 
patients’ medication history quality can also be considered 
one of the study limitations. 
The small number of patients, the observation of 
only two clinics in a single health facility and the short 
follow-up time are the main limitations of the study, 
suggesting caution in extrapolating the results to other 
health facilities. However, the study showed both the 
relevance as the feasibility of incorporating reconciliation 
in hospital routine. Unfortunately, the activity was not 
included in the pharmacists´ routine because of the lack 
of human resources.
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